BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2311407)

  • 1. Effects of enalapril on human sperm motility.
    Ratnasooriya WD; Jayawardena KG; Wadsworth RM
    Contraception; 1990 Feb; 41(2):213-9. PubMed ID: 2311407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the prostanoid receptor antagonist, di-4-phloretin phosphate, upon human sperm motility.
    Ratnasooriya WD; Premakumara GA
    Contraception; 1992 Mar; 45(3):239-48. PubMed ID: 1511609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sperm antimotility properties of a seed extract of Abrus precatorius.
    Ratnasooriya WD; Amarasekera AS; Perera NS; Premakumara GA
    J Ethnopharmacol; 1991; 33(1-2):85-90. PubMed ID: 1943179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ace-inhibitors, calmodulin antagonists, acetylcholine receptor blocking, and alpha receptor blocking agents on motility of human sperm.
    Placzek R; Krassnigg F; Schill WB
    Arch Androl; 1988; 21(1):1-10. PubMed ID: 2903725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of kininase II inhibitors on bradykinin-stimulated bovine sperm motility.
    Somlev B; Subev M
    Theriogenology; 1998 Sep; 50(4):651-7. PubMed ID: 10732155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of captopril on human sperm motility parameters in vitro].
    Yao HX; Liu JH
    Zhonghua Nan Ke Xue; 2006 May; 12(5):435-7. PubMed ID: 16755876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-lymphocyte and plasma angiotensin-converting enzyme activity during enalapril and losartan administration in humans.
    Petrov VV; Fagard RH; Lijnen PJ
    J Cardiovasc Pharmacol; 2001 Oct; 38(4):578-83. PubMed ID: 11588528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor antagonism on renal sodium and water handling and albuminuria during infusion of atrial natriuretic factor into healthy volunteers.
    Vervoort G; Hertenberg F; Wetzels JF; Smits P
    J Hypertens; 1998 Feb; 16(2):245-50. PubMed ID: 9535153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal effects of angiotensin I-receptor blockade and angiotensin convertase inhibition in man.
    Schmitt F; Natov S; Martinez F; Lacour B; Hannedouche TP
    Clin Sci (Lond); 1996 Mar; 90(3):205-13. PubMed ID: 8777826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of angiotensin-converting enzyme (ACE) in reproductive tissues of the stallion and effects of angiotensin II on sperm motility.
    Ball BA; Gravance CG; Wessel MT; Sabeur K
    Theriogenology; 2003 Feb; 59(3-4):901-14. PubMed ID: 12517392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of enalapril on vasoactive intestinal peptide metabolism and tissue levels.
    Duggan KA; Ye VZ
    Eur J Pharmacol; 1998 Sep; 358(1):25-30. PubMed ID: 9809865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of IGF-I on buffalo (Bubalus bubalis) spermatozoa motility, membrane integrity, lipid peroxidation and fructose uptake in vitro.
    Selvaraju S; Reddy IJ; Nandi S; Rao SB; Ravindra JP
    Anim Reprod Sci; 2009 Jul; 113(1-4):60-70. PubMed ID: 18804927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II stimulates sperm motility.
    Vinson GP; Mehta J; Evans S; Matthews S; Puddefoot JR; Saridogan E; Holt WV; Djahanbakhch O
    Regul Pept; 1996 Dec; 67(2):131-5. PubMed ID: 8958584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of the angiotensin converting enzyme inhibitors captopril and enalapril on the conversion of procollagen to collagen.
    Männistö TK; Karvonen KE; Kerola TV; Ryhänen LJ
    J Hypertens; 2001 Oct; 19(10):1835-9. PubMed ID: 11593104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin I-converting enzyme inhibition but not angiotensin II suppression alters angiotensin I-converting enzyme gene expression in vessels and epithelia.
    Costerousse O; Allegrini J; Clozel JP; Ménard J; Alhenc-Gelas F
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1180-7. PubMed ID: 9495881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enalapril, an inhibitor of angiotensin converting enzyme, increases the junctional conductance in isolated heart cell pairs.
    De Mello WC; Altieri P
    J Cardiovasc Pharmacol; 1991 Oct; 18(4):643-6. PubMed ID: 1724543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term angiotensin-converting enzyme inhibition with high-dose enalapril retards nitrate tolerance in large epicardial arteries and prevents rebound coronary vasoconstriction in vivo.
    Münzel T; Bassenge E
    Circulation; 1996 Jun; 93(11):2052-8. PubMed ID: 8640982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The angiotensin converting enzyme inhibitors fosinopril and enalapril differ in their central nervous effects in humans.
    Derad I; Otterbein A; Mölle M; Pietrowsky R; Born J; Fehm HL
    J Hypertens; 1996 Nov; 14(11):1309-15. PubMed ID: 8934359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The angiotensin converting enzyme inhibitors captopril and enalapril inhibit apomorphine-induced oral stereotypy in the rat.
    Banks RJ; Mozley L; Dourish CT
    Neuroscience; 1994 Feb; 58(4):799-805. PubMed ID: 8190257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against L-NAME-induced reduction in cardiac output persists even after cessation of angiotensin-converting enzyme inhibitor treatment.
    Biwer LA; Broderick TL; Xu H; Carroll C; Hale TM
    Acta Physiol (Oxf); 2013 Jan; 207(1):156-65. PubMed ID: 22834875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.